2023 Q3 Form 10-Q Financial Statement

#000147793223005899 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q4
Revenue $10.13M $83.65K $130.7K
YoY Change 6291.44% -51.27% -3.29%
Cost Of Revenue $6.654M $32.02K $31.52K
YoY Change 12926.07% -22.6% -13.74%
Gross Profit $3.477M $51.63K $99.17K
YoY Change 3136.86% -60.37% 0.58%
Gross Profit Margin 34.32% 61.72% 75.88%
Selling, General & Admin $3.557M $2.126M $1.268M
YoY Change 168.2% 93.83% -16.81%
% of Gross Profit 102.3% 4117.04% 1278.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $692.5K $2.720K $5.650K
YoY Change 25322.91% -5.23% 98.94%
% of Gross Profit 19.92% 5.27% 5.7%
Operating Expenses $10.67M $2.160M $1.273M
YoY Change 673.38% 89.36% -16.59%
Operating Profit -$543.4K -$2.077M -$1.174M
YoY Change -55.52% 114.27% -17.78%
Interest Expense $421.3K $1.176M -$20.06M
YoY Change -72.9% 46.09% -125.63%
% of Operating Profit
Other Income/Expense, Net -$21.82M $3.998M $331.2K
YoY Change -1.08% -28.16%
Pretax Income -$22.36M $1.921M -$20.90M
YoY Change -3.94% -58.2% -127.21%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$22.36M $1.921M -$20.90M
YoY Change -3.94% -58.2% -127.21%
Net Earnings / Revenue -220.75% 2296.21% -15992.65%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.28 $0.08 -$1.44
COMMON SHARES
Basic Shares Outstanding 88.45M shares 22.63M shares 719.1M shares
Diluted Shares Outstanding 22.62M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.433M $137.5K $1.167M
YoY Change -41.66% -93.75% -80.07%
Cash & Equivalents $1.433M $137.5K $1.167M
Short-Term Investments
Other Short-Term Assets $482.9K $283.3K $56.83K
YoY Change 239.88% 24.63% 0.0%
Inventory $9.533M $10.28M
Prepaid Expenses $283.3K $56.83K
Receivables $6.496M $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $17.94M $420.8K $1.223M
YoY Change 590.78% -82.71% -79.39%
LONG-TERM ASSETS
Property, Plant & Equipment $1.604M $60.70K $63.27K
YoY Change 2393.02% -7.64% -8.14%
Goodwill $52.97M $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments $25.31M $26.84M
YoY Change -26.21% -26.07%
Other Assets $1.941M $4.852M $6.572M
YoY Change -71.55% -39.51% 60.3%
Total Long-Term Assets $83.83M $30.22M $33.47M
YoY Change 140.05% -28.7% -17.29%
TOTAL ASSETS
Total Short-Term Assets $17.94M $420.8K $1.223M
Total Long-Term Assets $83.83M $30.22M $33.47M
Total Assets $101.8M $30.64M $34.70M
YoY Change 171.26% -31.63% -25.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.288M $1.488M $791.5K
YoY Change 254.78% 21.65% -45.39%
Accrued Expenses $7.987M $4.512M $3.550M
YoY Change 144.71% 73.26% 68.73%
Deferred Revenue
YoY Change
Short-Term Debt $4.325M $0.00 $0.00
YoY Change
Long-Term Debt Due $2.743K $35.52M $33.93M
YoY Change -99.99% 9.96% 57.8%
Total Short-Term Liabilities $27.40M $11.07M $17.83M
YoY Change -26.79% -72.93% -81.55%
LONG-TERM LIABILITIES
Long-Term Debt $38.85M $35.52M $33.93M
YoY Change 17.31% 9.96% 57.8%
Other Long-Term Liabilities $5.756M $64.52K $61.55K
YoY Change 10002.56% 15.98% 16.0%
Total Long-Term Liabilities $38.85M $35.52M $33.93M
YoY Change 17.31% 9.96% 57.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.40M $11.07M $17.83M
Total Long-Term Liabilities $38.85M $35.52M $33.93M
Total Liabilities $72.58M $46.66M $51.82M
YoY Change 2.81% -36.31% -56.17%
SHAREHOLDERS EQUITY
Retained Earnings -$147.4M -$589.5M -$589.0M
YoY Change -74.06% -208.19% -222.39%
Common Stock $107.5K $26.54K $18.09K
YoY Change -80.34% -94.2% -92.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.08M -$16.02M -$17.12M
YoY Change
Total Liabilities & Shareholders Equity $101.8M $30.64M $34.70M
YoY Change 171.26% -31.63% -25.23%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income -$22.36M $1.921M -$20.90M
YoY Change -3.94% -58.2% -127.21%
Depreciation, Depletion And Amortization $692.5K $2.720K $5.650K
YoY Change 25322.91% -5.23% 98.94%
Cash From Operating Activities -$2.213M -$1.662M -$1.539M
YoY Change 134.43% 65.02% 27.16%
INVESTING ACTIVITIES
Capital Expenditures $133.4K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.565M $1.225M $250.0K
YoY Change -230.42% 226.67% -106.1%
Cash From Investing Activities -$1.698M $1.225M $250.0K
YoY Change -241.54% 226.67% -106.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.012M 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -2.213M -1.662M -1.539M
Cash From Investing Activities -1.698M 1.225M 250.0K
Cash From Financing Activities 3.012M 0.000 0.000
Net Change In Cash -899.1K -437.5K -1.289M
YoY Change -451.07% -78.21% -286.94%
FREE CASH FLOW
Cash From Operating Activities -$2.213M -$1.662M -$1.539M
Capital Expenditures $133.4K
Free Cash Flow -$2.346M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001309082
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26538285 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18092663 shares
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
93981234 usd
cei Beneficial Ownership Percentage
BeneficialOwnershipPercentage
0.609 pure
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0 usd
CY2023Q2 cei Dilutive Effect Of Common Stock Equivalents Options Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsWarrants
0 shares
CY2022Q2 cei Dilutive Effect Of Common Stock Equivalents Options Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsWarrants
0 shares
cei Dilutive Effect Of Common Stock Equivalents Options Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsWarrants
0 shares
cei Dilutive Effect Of Common Stock Equivalents Options Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsWarrants
0 shares
CY2023Q2 cei Preferred C Shares
PreferredCShares
0 shares
CY2022Q2 cei Preferred C Shares
PreferredCShares
0 shares
cei Preferred C Shares
PreferredCShares
0 shares
cei Preferred C Shares
PreferredCShares
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-29219
dei Entity Registrant Name
EntityRegistrantName
CAMBER ENERGY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2660243
dei Entity Address Address Line1
EntityAddressAddressLine1
15915 Katy Freeway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 450
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77094
dei City Area Code
CityAreaCode
281
dei Local Phone Number
LocalPhoneNumber
404 4387
dei Security12b Title
Security12bTitle
Common Stock, $0.001 Par Value Per Share
dei Trading Symbol
TradingSymbol
CEI
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
88449690 shares
CY2023Q2 us-gaap Cash
Cash
137485 usd
CY2022Q4 us-gaap Cash
Cash
1166596 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
283333 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
56833 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
420818 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1223429 usd
CY2023Q2 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
60701 usd
CY2022Q4 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
63267 usd
CY2023Q2 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
60701 usd
CY2022Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
63267 usd
CY2023Q2 cei Due From Viking Energy Group Inc
DueFromVikingEnergyGroupInc
4852300 usd
CY2022Q4 cei Due From Viking Energy Group Inc
DueFromVikingEnergyGroupInc
6572300 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
25306586 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
26837718 usd
CY2023Q2 us-gaap Assets
Assets
30640405 usd
CY2022Q4 us-gaap Assets
Assets
34696714 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1487924 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
791499 usd
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4511940 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3549620 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
3000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3000 usd
CY2023Q2 cei Warrants Liability
WarrantsLiability
0 usd
CY2022Q4 cei Warrants Liability
WarrantsLiability
5894179 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5069152 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
7592744 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11072016 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17831042 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
35523337 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
33927760 usd
CY2023Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
64523 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
61545 usd
CY2023Q2 us-gaap Liabilities
Liabilities
46659876 usd
CY2022Q4 us-gaap Liabilities
Liabilities
51820347 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26538285 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18092663 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
26538 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
18093 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
573409360 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
571888348 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-589455375 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-589030080 usd
CY2023Q2 cei Stockholder Equity
StockholderEquity
-16019471 usd
CY2022Q4 cei Stockholder Equity
StockholderEquity
-17123633 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30640405 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34696714 usd
CY2023Q2 cei Oil And Gas Sales
OilAndGasSales
83648 usd
CY2022Q2 cei Oil And Gas Sales
OilAndGasSales
171651 usd
cei Oil And Gas Sales
OilAndGasSales
177119 usd
cei Oil And Gas Sales
OilAndGasSales
308058 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
32015 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
41365 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
75100 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
90730 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2125630 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1096624 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3544844 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2074614 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
123754 usd
CY2023Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
2722 usd
CY2022Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
2870 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
5544 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
5737 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2160367 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1140859 usd
us-gaap Operating Expenses
OperatingExpenses
3625488 usd
us-gaap Operating Expenses
OperatingExpenses
2294835 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2076719 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-969208 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3448369 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1986777 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
1175814 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
804857 usd
us-gaap Interest Expense
InterestExpense
2334107 usd
us-gaap Interest Expense
InterestExpense
1966132 usd
CY2023Q2 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-433293 usd
CY2022Q2 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-1038680 usd
us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-1531132 usd
us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-2004560 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
5606607 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
7407750 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
6888313 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-57602973 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3997500 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5564213 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3023074 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-61573665 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1920781 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4595005 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-425295 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-63560442 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
1920781 usd
CY2022Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
4595005 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-425295 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-63560442 usd
CY2023Q2 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 usd
CY2022Q2 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1920781 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
4595005 usd
us-gaap Net Income Loss
NetIncomeLoss
-425295 usd
us-gaap Net Income Loss
NetIncomeLoss
-63560442 usd
CY2023Q2 cei Earning Per Shares Basic And Diluted
EarningPerSharesBasicAndDiluted
0.08
CY2022Q2 cei Earning Per Shares Basic And Diluted
EarningPerSharesBasicAndDiluted
0.58
cei Earning Per Shares Basic And Diluted
EarningPerSharesBasicAndDiluted
-0.02
cei Earning Per Shares Basic And Diluted
EarningPerSharesBasicAndDiluted
-9.01
CY2023Q2 cei Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
22619571 shares
CY2022Q2 cei Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
7904151 shares
cei Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
21177232 shares
cei Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
7056682 shares
us-gaap Net Income Loss
NetIncomeLoss
-425295 usd
us-gaap Net Income Loss
NetIncomeLoss
-63560442 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
123754 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5544 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5737 usd
cei Change In Fair Value Of Derivative And Warrant Liability
ChangeInFairValueOfDerivativeAndWarrantLiability
-6888313 usd
cei Change In Fair Value Of Derivative And Warrant Liability
ChangeInFairValueOfDerivativeAndWarrantLiability
57602973 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1595577 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1569131 usd
us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-1531132 usd
us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-2004560 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18005 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
198500 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-170500 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1233744 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
274278 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2749111 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2132504 usd
cei Loans To Viking
LoansToViking
0 usd
cei Loans To Viking
LoansToViking
3922300 usd
cei Repayments Received From Viking
RepaymentsReceivedFromViking
1720000 usd
cei Repayments Received From Viking
RepaymentsReceivedFromViking
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1720000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3922300 usd
cei Proceeds From Issuance Of Series C Preferred Stock
ProceedsFromIssuanceOfSeriesCPreferredStock
0 usd
cei Proceeds From Issuance Of Series C Preferred Stock
ProceedsFromIssuanceOfSeriesCPreferredStock
-18850000 usd
cei Proceeds From Issuance Of Series G Preferred Stock
ProceedsFromIssuanceOfSeriesGPreferredStock
0 usd
cei Proceeds From Issuance Of Series G Preferred Stock
ProceedsFromIssuanceOfSeriesGPreferredStock
-2750000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
25000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2400000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1029111 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3654804 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1166596 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5854382 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137485 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2199578 usd
us-gaap Interest Paid Net
InterestPaidNet
5232 usd
us-gaap Interest Paid Net
InterestPaidNet
63368 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Premiums Earned Net Other Insurance
PremiumsEarnedNetOtherInsurance
425000 usd
us-gaap Premiums Earned Net Other Insurance
PremiumsEarnedNetOtherInsurance
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-17123633 usd
cei Conversion Of Series C Preferred Stock Amount
ConversionOfSeriesCPreferredStockAmount
0 usd
cei True Up Shares Amount
TrueUpSharesAmount
1529457 usd
us-gaap Net Income Loss
NetIncomeLoss
-425295 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-16019471 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-71813552 usd
cei Conversion Of Series C Preferred Stock Amount
ConversionOfSeriesCPreferredStockAmount
88229511 usd
cei True Up Shares Amount
TrueUpSharesAmount
25412740 usd
cei Issuance Of Common Shares For Consulting Fees Amount
IssuanceOfCommonSharesForConsultingFeesAmount
123754 usd
cei Redemption Of Series C Preferred Share For Cash Amount
RedemptionOfSeriesCPreferredShareForCashAmount
-18850000 usd
cei Redemption Of Series G Preferred Stocks Amount
RedemptionOfSeriesGPreferredStocksAmount
-2750000 usd
cei Warrant Issued For Debt Discount
WarrantIssuedForDebtDiscount
14763393 usd
us-gaap Net Income Loss
NetIncomeLoss
-63560442 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-28444597 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 2 – ORGANIZATION AND OPERATIONS OF THE COMPANY</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Camber’s aim is to become a growth-oriented diversified energy company. The Company owns minority, non-operated working interests in certain oil &amp; gas wells in Texas and/or Louisiana, and through its investment in Viking, the organization provides custom energy &amp; power solutions to commercial and industrial clients in North America. Viking also holds an exclusive license in Canada to a patented carbon-capture system, and has a majority interest in: (i) an entity with intellectual property rights to a fully developed, patented, proprietary Medical &amp; Bio-Hazard Waste Treatment system using Ozone Technology; and (ii) entities with the intellectual property rights to fully developed, patent pending, proprietary Electric Transmission and Distribution Open Conductor Detection Systems. </p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts and timing of revenues and expenses, the reported amounts and classification of assets and liabilities, and disclosure of contingent assets and liabilities. Significant areas requiring the use of management estimates relate to the determination of fair value of the Company’s Series C Preferred stock, impairment of long-lived assets, stock-based compensation, asset retirement obligations, and the determination of expected tax rates for future income tax recoveries.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The estimates of proved, probable and possible oil and gas reserves are used as significant inputs in determining the depletion of oil and gas properties and the impairment of proved and unproved oil and gas properties. There are numerous uncertainties inherent in the estimation of quantities of proved, probable and possible reserves and in the projection of future rates of production and the timing of development expenditures. Similarly, evaluations for impairment of proved and unproved oil and gas properties are subject to numerous uncertainties including, among others, estimates of future recoverable reserves and commodity price outlooks. Actual results could differ from the estimates and assumptions utilized.</p>
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q2 us-gaap Fdic Indemnification Asset
FDICIndemnificationAsset
0 usd
CY2022Q4 us-gaap Fdic Indemnification Asset
FDICIndemnificationAsset
916596 usd
CY2022Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
63267 usd
CY2023Q2 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
60701 usd
CY2022Q4 us-gaap Oil And Gas Property Full Cost Method Depletion
OilAndGasPropertyFullCostMethodDepletion
78370049 usd
CY2023Q2 us-gaap Oil And Gas Property Full Cost Method Depletion
OilAndGasPropertyFullCostMethodDepletion
78372615 usd
CY2023Q2 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
46815789 usd
CY2022Q4 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
46815789 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
11292452 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
12888029 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
35523337 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
26837718 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
36299592 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-1531132 usd
CY2022 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-9461874 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
25306586 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
26837718 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
61545 usd
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
53055 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
2978 usd
CY2022 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
8490 usd
CY2023Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
64523 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
61545 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33927760 usd
CY2023Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0 usd
CY2023Q2 cei Net Long Term Debt
NetLongTermDebt
35523337 usd
CY2022Q4 cei Net Long Term Debt
NetLongTermDebt
33927760 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
35523337 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
0 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
35523337 usd
us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
162.50
cei Conversion Premium Dividend Rate
ConversionPremiumDividendRate
0.2495 pure
cei Increased Conversion Premium Dividend
IncreasedConversionPremiumDividend
0.3495 pure
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company declared four reverse stock splits in 2018 and 2019 and the Company’s common stock generally trades at less than $1.00 per share
CY2022Q4 cei Carrying Amount At Beginning Of Period
CarryingAmountAtBeginningOfPeriod
7592744 usd
CY2021Q4 cei Carrying Amount At Beginning Of Period
CarryingAmountAtBeginningOfPeriod
93108568 usd
cei Issued Series C Preferred Shares
IssuedSeriesCPreferredShares
0 usd
CY2022 cei Issued Series C Preferred Shares
IssuedSeriesCPreferredShares
0 usd
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
994134 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
89523091 usd
cei Settlement Of Obligation Issuance Of Common Shares
SettlementOfObligationIssuanceOfCommonShares
-1529458 usd
CY2022 cei Settlement Of Obligation Issuance Of Common Shares
SettlementOfObligationIssuanceOfCommonShares
-175038915 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5069152 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
7592744 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
60000 usd
cei Overriding Royalty Interest
OverridingRoyaltyInterest
0.04 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
177119 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
308058 usd
cei Issuance Of Shares For Consulting Amount
IssuanceOfSharesForConsultingAmount
3947999 usd
CY2023Q2 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
6154 shares
CY2022Q4 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
16615 shares
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5430982 shares
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3758845 shares
CY2023Q2 cei Dilution Of The Company S Existing Shareholders
DilutionOfTheCompanySExistingShareholders
5437136 shares
CY2022Q4 cei Dilution Of The Company S Existing Shareholders
DilutionOfTheCompanySExistingShareholders
3775460 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2500000 shares
CY2021Q1 cei Description Of Increase Number Of Authorized Common Stock
DescriptionOfIncreaseNumberOfAuthorizedCommonStock
from 25,000,000 to 250,000,000
CY2021Q4 cei Description Of Increase Number Of Authorized Common Stock
DescriptionOfIncreaseNumberOfAuthorizedCommonStock
from 250,000,000 to 1,000,000,000
CY2022Q4 cei Description Of Increase Number Of Authorized Common Stock
DescriptionOfIncreaseNumberOfAuthorizedCommonStock
from 1,000,000,000 to 20,000,000
CY2023Q2 cei Description Of Increase Number Of Authorized Common Stock
DescriptionOfIncreaseNumberOfAuthorizedCommonStock
from 20,000,000 to 500,000,000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1920781 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4595005 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-425295 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-63560442 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22619571 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7904151 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21177232 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7056682 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22619571 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7904151 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21177232 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7056682 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.08
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.58
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-9.01
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.08
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.58
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-9.01

Files In Submission

Name View Source Status
R26.htm Edgar Link pending
0001477932-23-005899-index-headers.html Edgar Link pending
0001477932-23-005899-index.html Edgar Link pending
0001477932-23-005899.txt Edgar Link pending
0001477932-23-005899-xbrl.zip Edgar Link pending
cei-20230630.xsd Edgar Link pending
cei_10q.htm Edgar Link pending
cei_ex311.htm Edgar Link pending
cei_ex312.htm Edgar Link pending
cei_ex321.htm Edgar Link pending
cei_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
cei-20230630_cal.xml Edgar Link unprocessable
cei-20230630_def.xml Edgar Link unprocessable
cei-20230630_lab.xml Edgar Link unprocessable
cei-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cei_10q_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending